Cantel Medical Corp (CMN)

To play doctor all you need is a stethoscope, but for the real thing you need to worry about serious problems like infections. Cantel makes devices like sterilants and filters to stave off infection.

Show Chart

Cantel Medical Corp. to Present at the Needham & Company 12th Annual Growth Stock Conference


LITTLE FALLS, N.J., Jan. 5 /PRNewswire-FirstCall/ -- Cantel Medical Corp.
(NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Needham & Company, LLC 12th Annual Growth Stock Conference. The formal presentation is scheduled for 1:50 PM ET on Thursday, January 14, 2010 at The New York Palace Hotel, with a Q & A session immediately following the presentation. In addition, Mr. Krakauer and Seth R. Segel, Executive Vice President, will be available for separate one-on-one meetings during the day. The presentation will be available on the Investor Relations section of the Company's website: www.cantelmedical.com.


Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. ????For more information, please visit http://www.cantelmedical.com.


SOURCE Cantel Medical Corp.


Events

  • March 92012
    Cantel Medical Corp. expected to report Q2 2012 results on March 9, 2012. This event was calculated by Capital IQ (Created on December 9, 2011).
  • October132012
    Cantel Medical Corp. expected to report Fiscal Year 2012 results on October 13, 2012. This event was calculated by Capital IQ (Created on December 10, 2011).

Members who own this company also own

the fun, safe & free way to learn the stock market Free! Sign up now! or log in

Current price per share

Today's gain: $-0.55 (-2.50%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon

Sign up or Sign in or continue to Explore We Seed